These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17881351)

  • 1. Development of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry.
    Dharmasena MN; Jewell DA; Taylor RK
    J Biol Chem; 2007 Nov; 282(46):33805-33816. PubMed ID: 17881351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes.
    Dharmasena MN; Krebs SJ; Taylor RK
    Microbiology (Reading); 2009 Jul; 155(Pt 7):2353-2364. PubMed ID: 19389772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of
    Kim D; Hong J; Choi Y; Han J; Kim S; Jo G; Yoon JY; Chae H; Yoon H; Lee C; Hong HJ
    J Microbiol Biotechnol; 2020 Nov; 30(11):1760-1768. PubMed ID: 32876069
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics.
    Phalipon A; Folgori A; Arondel J; Sgaramella G; Fortugno P; Cortese R; Sansonetti PJ; Felici F
    Eur J Immunol; 1997 Oct; 27(10):2620-5. PubMed ID: 9368618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
    Villeneuve S; Boutonnier A; Mulard LA; Fournier JM
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of lipopolysaccharide-mimicking peptides and their immunoprotectivity against Vibrio cholerae serogroup O1.
    Mohammad Pour Ghazi F; Gargari SL
    J Pept Sci; 2016 Nov; 22(11-12):682-688. PubMed ID: 27766741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of phage-displayed peptides recognised by monoclonal antibodies directed against the lipopolysaccharide of Brucella.
    Mertens P; Walgraffe D; Laurent T; Deschrevel N; Letesson JJ; De Bolle X
    Int Rev Immunol; 2001; 20(2):181-99. PubMed ID: 11878764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of synthetic analogs of the upstream, terminal residue of the O-polysaccharides (O-PS) of Vibrio cholerae O:1 serotypes Ogawa and Inaba to two murine monoclonal antibodies (MAbs) specific for the Ogawa lipopolysaccharide (LPS).
    Liao X; Poirot E; Chang AH; Zhang X; Zhang J; Nato F; Fournier JM; Kovác P; Glaudemans CP
    Carbohydr Res; 2002 Nov; 337(24):2437-42. PubMed ID: 12493228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharides of Escherichia coli K12 strains that express cloned genes for the Ogawa and Inaba antigens of Vibrio cholerae O1: identification of O-antigenic factors.
    Hisatsune K; Kondo S; Iguchi T; Ito T; Hiramatsu K
    Microbiol Immunol; 1996; 40(9):621-6. PubMed ID: 8908606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba.
    Wang J; Villeneuve S; Zhang J; Lei P; Miller CE; Lafaye P; Nato F; Szu SC; Karpas A; Bystricky S; Robbins JB; Kovác P; Fournier JM; Glaudemans CP
    J Biol Chem; 1998 Jan; 273(5):2777-83. PubMed ID: 9446585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies.
    Meeks MD; Saksena R; Ma X; Wade TK; Taylor RK; Kovác P; Wade WF
    Infect Immun; 2004 Jul; 72(7):4090-101. PubMed ID: 15213154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides mimicking Vibrio cholerae O139 capsular polysaccharide elicit protective antibody response.
    Falklind-Jerkérus S; Felici F; Cavalieri C; Lo Passo C; Garufi G; Pernice I; Islam MM; Qadri F; Weintraub A
    Microbes Infect; 2005 Dec; 7(15):1453-60. PubMed ID: 16046165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa.
    Saksena R; Ma X; Wade TK; Kovác P; Wade WF
    Carbohydr Res; 2005 Oct; 340(14):2256-69. PubMed ID: 16098493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epitope analysis of an antibody specifically against Vibrio cholerae O1 Ogawa by phage library study.
    Cheng S; Lin Z; Liu X; Zheng W; Lu G; Tu Z; Zhang J; Zheng J; Yu X
    J Microbiol Methods; 2015 Oct; 117():22-7. PubMed ID: 26172085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The O polysaccharide chain of the lipopolysaccharide from Vibrio cholerae O76 is a homopolymer of N-[(S)-(+)-2-hydroxypropionyl]-alpha-L-perosamine.
    Kondo S; Sano Y; Isshiki Y; Hisatsune K
    Microbiology (Reading); 1996 Oct; 142 ( Pt 10)():2879-85. PubMed ID: 8885404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An N-[(R)-(-)-2-hydroxypropionyl]-alpha-L-perosamine homopolymer constitutes the O polysaccharide chain of the lipopolysaccharide from Vibrio cholerae O144 which has antigenic factor(s) in common with V. cholerae O76.
    Sano Y; Kondo S; Isshiki Y; Shimada T; Hisatsune K
    Microbiol Immunol; 1996; 40(10):735-41. PubMed ID: 8981346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier.
    Chernyak A; Kondo S; Wade TK; Meeks MD; Alzari PM; Fournier JM; Taylor RK; Kovác P; Wade WF
    J Infect Dis; 2002 Apr; 185(7):950-62. PubMed ID: 11920320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity.
    Villeneuve S; Souchon H; Riottot MM; Mazie JC; Lei P; Glaudemans CP; Kovác P; Fournier JM; Alzari PM
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8433-8. PubMed ID: 10880560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of
    Kauffman RC; Adekunle O; Yu H; Cho A; Nyhoff LE; Kelly M; Harris JB; Bhuiyan TR; Qadri F; Calderwood SB; Charles RC; Ryan ET; Kong J; Wrammert J
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879588
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential of peptides selected from random phage-displayed libraries to mimic conformational epitopes: a study on scorpion toxin Cn2 and the neutralizing monoclonal antibody BCF2.
    Gazarian TG; Selisko B; Gurrola GB; Hernández R; Possani LD; Gazarian KG
    Comb Chem High Throughput Screen; 2003 Mar; 6(2):119-32. PubMed ID: 12678707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.